BAJAJ BROKING
Dr Reddy’s Laboratories inaugurated a 70,000 sq ft biologics facility in Genome Valley, Hyderabad, through its subsidiary Aurigene, emphasising process and analytical development for antibodies and recombinant proteins. It aligns with Dr Reddy’s commitment to advancing biologics research and development.
Dr Reddy’s Laboratories revealed the inauguration of a new biologics facility spanning 70,000 sq ft in Genome Valley, Hyderabad, operated by its subsidiary, Aurigene Pharmaceutical Services Limited. The facility aims to address process and analytical development and small-scale manufacturing requirements for antibodies and other recombinant proteins.
Explore: Dr. Reddy's Laboratories
While the process and analytical development laboratories are already operational, the manufacturing capacity is slated for completion later in 2024, as per a regulatory filing by Dr Reddy’s Labs.
This addition complements the company’s existing infrastructure, concentrating on various recombinant proteins such as monoclonal antibodies (mAbs), bi- and multi-specifics, and immune-fusion molecules.
Aurigene's service spectrum now covers discovery to large-scale commercial manufacturing, facilitated by three nearby campuses. This alignment ensures seamless progression from conceptualization to commercialization, catering to diverse customer needs.
Aurigene CEO Akhil Ravi expressed confidence that the new facility's capabilities will enhance global customer service and support innovative medicine development.
Dr Roger Lias, Aurigene's global commercial head for biologics, emphasised the rarity of global CDMOs providing end-to-end services, highlighting Aurigene's strengthened capabilities and technical prowess.
The industry also witnessed Aurobindo Pharma's subsidiary, TheraNym Biologics Pvt Ltd, securing a contract manufacturing agreement with Merck Sharpe & Dohme Singapore Trading Pte Ltd for biological production. Additionally, researchers at IISc introduced a safer protein production method using MSG, replacing hazardous methanol.
This comprehensive expansion underscores Dr Reddy’s commitment to strengthening its biologics capabilities and serving the evolving needs of the pharmaceutical industry.
Additional Read: Dr. Reddy's Laboratories Ltd.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Textile Sector in India
20 Sep, 2024 | 11 Min. read
Commodities Market Today | WTI Crude Rises 1.4%, Gold And Silver Prices Increase
20 Sep, 2024 | 1 Min. read
Share Market Today | Gift Nifty Hints At A Positive Opening For Indian Markets
20 Sep, 2024 | 4 Min. read
AU Small Finance Bank Partners With Niva Bupa Health Insurance
20 Sep, 2024 | 4 Min. read
Adani Group To Acquire 46.64% Stake in ITD Cementation India
20 Sep, 2024 | 4 Min. read
NTPC Approves ₹9,701 Crore Investment In Sipat Stage-III
20 Sep, 2024 | 4 Min. read
SEBI Bars Axis Capital From New Debt Segment Roles
20 Sep, 2024 | 4 Min. read
Gold Rate Today | Gold Rises 0.5%, Silver Increases 1.5%
20 Sep, 2024 | 2 Min. read
Hong Kong Cuts Interest Rates by 0.5% After Fed Eases
19 Sep, 2024 | 4 Min. read
NTPC Green Energy Files ₹10,000 Crore IPO Draft
19 Sep, 2024 | 4 Min. read
US Federal Reserve Cuts Interest Rates by 0.5%
19 Sep, 2024 | 4 Min. read
Margin in Leverage Trading: Definition, Working & Differences
19 Sep, 2024 | 4 Min. read
Analysis to Become a Pro Investor
28 Dec, 2023 | 4 Min. read
Women In Real Estate Investing (Investree)
28 Dec, 2023 | 5 Min. read
How To Check Prudent Corporate Advisory IPO Allotment Status
27 Dec, 2023 | 3 Min. read
How To Boost Credit Score? – Steps to Improve Creditworthiness
27 Dec, 2023 | 4 Min. read
Advantages and Disadvantages of Opening Multiple Demat Accounts
26 Dec, 2023 | 4 Min. read
7th CPC LTC: Leave Travel Concession Rules for Central Government Employees
26 Dec, 2023 | 4 Min. read
7th Pay Commission: House Building Advance (HBA) Interest Rate FY 2023-24
26 Dec, 2023 | 5 Min. read
The Future of Trading: Exploring Bajaj Broking’s Demat Features
26 Dec, 2023 | 6 Min. read
7th Central Pay Commission Cpc Fitment Table
23 Dec, 2023 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading